Skip to content

XOMA Corporation XOMA Market capitalization

Market capitalization at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$3.98B+96.7%
Royalty Pharma logo
Royalty PharmaRPRX
$20.55B+52.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$835.73M+89.2%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$1.73B+51.8%
Zymeworks logo
ZymeworksZYME
$1.86B+125%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Enterprise value$784.29M+151%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Computed from the period-end share price: $373.48M.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's market capitalization?
XOMA Corporation (XOMA) reported market capitalization of $373.48M in Q1 2026.
How has XOMA Corporation's market capitalization changed year-over-year?
XOMA Corporation's market capitalization increased by 56.4% year-over-year, from $238.74M to $373.48M.
What is the long-term trend for XOMA Corporation's market capitalization?
Over 5 years (2020 to 2025), XOMA Corporation's market capitalization has grown at a -8.0% compound annual growth rate (CAGR), from $499.16M to $329.27M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.